Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kebotix was not a therapeutics company and had no clinical-stage drug programs; it provided an AI- and robotics-powered platform to partners (including NIH NCATS) to accelerate discovery and optimization of chemicals, materials, and assay conditions, with demonstrated large reductions in experimental time and cost for applications such as virus-detection assays and material optimization.[2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kebotix.